Sorafenib: Mechanism of Action
0:16
Sorafenib: Mechanism of Action
327 viewsApr 6, 2025
YouTubeLegacius Pharma
HCC Treatment: Sorafenib TACE | OncLive
HCC Treatment: Sorafenib TACE | OncLive
Jul 27, 2018
onclive.com
Dr. Rini on the Results From His Axitinib and Sorafenib Trial | OncLive
Dr. Rini on the Results From His Axitinib and Sorafenib Trial | OncL…
Jun 24, 2011
onclive.com
Sorafenib Initiation After TACE in HCC | OncLive
Sorafenib Initiation After TACE in HCC | OncLive
Nov 28, 2018
onclive.com
141. Time-Programmed Delivery of Sorafenib and Anti-CD47 Antibody via a Double-Layer-Gel Matrix for Postsurgical Treatment of Breast Cance https://link.springer.com/article/10.1007/s40820-021-00647-x | Nano-Micro Letters
0:18
141. Time-Programmed Delivery of Sorafenib and Anti-CD47 Antibod…
10.1K viewsJun 19, 2021
FacebookNano-Micro Letters
Managing Sorafenib-Related AEs in Thyroid Cancer | OncLive
Managing Sorafenib-Related AEs in Thyroid Cancer | OncLive
Jul 9, 2014
onclive.com
HCC: Considerations in First-Line Use of Sorafenib | OncLive
HCC: Considerations in First-Line Use of Sorafenib | OncLive
Oct 31, 2016
onclive.com
Dr. Rini on the Axitinib and Sorafenib Trial Hazard Ratio | Onc…
Jun 27, 2011
onclive.com
Dr. Brose Discusses Lenvatinib and Sorafenib in Differentiated Thyroi…
Nov 2, 2014
onclive.com
2:22
Pharmacology of Sorafenib (Soratib, Sorafenat); Pharmacokinetics, Me…
332 viewsApr 13, 2025
YouTubeMBBS NAIJA
Sorafenib – skuteczność, wskazania, dawkowanie i skutki u…
7 months ago
abczdrowie.pl
Dr. El-Khoueiry on Choosing Between Lenvatinib and Sorafeni…
Jun 12, 2019
onclive.com
Dr. Brose on Sorafenib in RAI-Resistant Thyroid Cancer | OncLive
Jun 2, 2013
onclive.com
8:15
Camrelizumab Plus Rivoceranib vs Sorafenib as First-Line Therapy fo…
Jun 24, 2024
onclive.com
Dr. Armaghany on Frontline Sorafenib Versus Lenvatinib in Un…
Apr 4, 2020
onclive.com
Dr. Abou-Alfa on Doxorubicin Plus Sorafenib in Liver Cancer | OncLive
Mar 11, 2013
onclive.com
Dr. Dawson on the Addition of SBRT to Sorafenib in Locally Advanced …
Jan 21, 2023
onclive.com
Camrelizumab plus rivoceranib vs sorafenib as first-line therapy for …
Sep 30, 2022
onclive.com
Dr. Di Costanzo on the Effectiveness of Sorafenib in HCC | OncLive
May 24, 2017
onclive.com
DECISION Trial Supports Sorafenib in Thyroid Cancer | OncLive
Mar 27, 2015
onclive.com
Dr. Kudo on Cost-Effectiveness Analysis of Lenvatinib Versus Sor…
Sep 16, 2018
onclive.com
ASCO® GI 2025 Insights: Camrelizumab Rivoceranib vs. Sor…
Feb 25, 2025
vumedi.com
1:17
Inhibiting DKK1 enhances sorafenib efficacy in HCC
95 viewsNov 28, 2023
YouTubeAJE Video Bytes
6:27
NCCN Guidelines for First-Line Treatment of RR-DTC
161 viewsAug 3, 2020
YouTubeTargeted Oncology
29:28
My PhD Presentation (2017), New anticancer drugs targeting VEGF…
744 viewsMay 6, 2020
YouTubeMedicinal Chemistry with Karmalawy
5:11
Case 1: Treatment Response Rates & the Role of IR
55 viewsDec 2, 2019
YouTubeTargeted Oncology
1:11
Regorafenib Vs Sorafenib in the Treatment of Liver Cancer
1.6K viewsJul 5, 2016
YouTubeTargeted Oncology
1:33
Sorafenib as maintenance therapy for patients with transplant-ineligi…
193 viewsMar 11, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
Kexing Biopharm's Sorafenib Generic Receives Approvals in Eg…
6 months ago
marketscreener.com
Dr. Vogelzang Discusses First-Line Axitinib in mRCC | OncLive
May 6, 2013
onclive.com
See more videos
Static thumbnail place holder